Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels-Reference-Cited by-同舟云学术

Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels

Published:2023-01 Issue:1 Volume:25 Page:100-108
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Ono Yoshihiro^ORCID,Inoue Yosuke^ORCID,Ito Hiromichi^ORCID,Sasaki Takashi^ORCID,Takeda Tsuyoshi,Ozaka Masato,Sasahira Naoki^ORCID,Hiratsuka Makiko,Matsueda Kiyoshi,Oba Atsushi,Sato Takafumi,Saiura Akio^ORCID,Takahashi Yu^ORCID

Funder

Taiho Pharmaceutical

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Pancreatic cancer surgery: the new R-status Counts;Strobel;Annals of surgery,2017

2. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial;Neoptolemos;Annals of surgery,2001

3. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma;Ferrone;J Clin Oncol : official journal of the American Society of Clinical Oncology,2006

4. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy;Hartwig;Ann Surg Oncol,2013

5. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy;Varadhachary;Ann Surg Oncol,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer;Annals of Surgical Oncology;2024-09-13

2. Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis;Pancreatology;2024-09

3. Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma;Cancers;2024-01-20

4. A label-free electrochemical biosensor based on a bimetallic organic framework for the detection of carbohydrate antigen 19-9;Analytical Methods;2024

5. Long‐term outcomes of neoadjuvant gemcitabine, nab‐paclitaxel, and S1 (GAS) in borderline resectable pancreatic cancer with arterial contact: Results from a phase II trial;Journal of Hepato-Biliary-Pancreatic Sciences;2023-12-29